Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Genet Mol Biol ; 44(2): e20200124, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33901269

RESUMO

MicroRNAs (miRNAs) dysregulation is tightly related to diseases including tumor, neuro disease and cardiovascular disease. In this study, we investigated the potential biological effects of miR-34a and its target CXCR3 in phenotypic modulation of vascular smooth muscle cells (VSMCs) of intracranial aneurysms (IAs). MiR-34a was found to be down-regulated in IAs patients tested by Real-time PCR and decreased in GEO data. Meanwhile, our study also showed miR-34a inhibited matrix metalloproteinases (MMPs) and migration of VSMCs. Besides, CXCR3 is a direct target of miR-34a identified via luciferase assay. CXCR3 showed inhibitory effect on SM-MHC, SM22 while promoted MMPs expression, cell proliferation and migration in VSMCs. MiR-34a reversed the effect of CXCR3 in VSMCs. In addition, MMP-2 is a competitive endogenous RNA (ceRNA) of CXCR3 sharing common miR-34a target. CXCR3 increased MMP-2 level through competitive endogenous RNA regulation by sponging endogenous miR-34a. In conclusion, miR-34a is down-regulated in IAs while CXCR3 is the direct target of miR-34a that regulates phenotypic modulation of VSMCs. CXCR3 increased MMP-2 level through competitive endogenous RNA regulation by sharing common miR-34a targets.

2.
Nanomaterials (Basel) ; 9(12)2019 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-31842262

RESUMO

Carbon nanotube (CNT) cold cathodes are proving to be compelling candidates for miniaturized terahertz (THz) vacuum electronic devices (VEDs) owning to their superior field-emission (FE) characteristics. Here, we report on the development of a multi-sheet beam CNT cold cathode electron optical system with concurrently high beam current and high current density. The microscopic FE characteristics of the CNT film emitter is captured through the development of an empirically derived macroscopic simulation model which is used to provide representative emission performance. Through parametrically optimized macroscale simulations, a five-sheet-beam triode electron gun has been designed, and has been shown to emit up to 95 mA at 3.2 kV. Through careful engineering of the electron gun geometric parameters, a low-voltage compact THz radiation source operating in high-order TM 5 , 1 mode is investigated to improve output power and suppress mode competition. Particle in cell (PIC) simulations show the average output power is 33 W at 0.1 THz, and the beam-wave interaction efficiency is approximately 10%.

3.
Biomed Pharmacother ; 102: 263-270, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29567539

RESUMO

This work aims to study the roles and mechanisms of metformin in glioma cells stemness and epithelial-mesenchymal transition. Here, we found that metformin suppressed glioma cells spheroid formation and size, inhibited the expression of glioma stemness-related marker, CD133. Additionally, Metformin attenuated TGF-ß-induced epithelial-mesenchymal transition in glioma cells. Mechanistically, metformin inhibited the nuclear abundance of YAP, a key effector of Hippo pathway, subsequently leading to its cytoplasmic retention, and thus reduced YAP transcriptional modulating activity. Importantly, overexpression of a mutant form of YAP (YAP-5SA) attenuated the inhibition of metformin on glioma cells stemness and epithelial-mesenchymal transition. Thus, metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Neoplasias do Sistema Nervoso Central/patologia , Transição Epitelial-Mesenquimal/efeitos dos fármacos , Glioma/patologia , Metformina/farmacologia , Células-Tronco Neoplásicas/efeitos dos fármacos , Fosfoproteínas/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/genética , Linhagem Celular Tumoral , Forma Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Neoplasias do Sistema Nervoso Central/metabolismo , Relação Dose-Resposta a Droga , Glioma/metabolismo , Humanos , Células-Tronco Neoplásicas/metabolismo , Células-Tronco Neoplásicas/patologia , Fosfoproteínas/genética , Transdução de Sinais , Fatores de Transcrição , Proteínas de Sinalização YAP
4.
Opt Express ; 25(17): 20477-20485, 2017 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-29041728

RESUMO

The terahertz band is an increasingly important spectrum in a wide range of applications from bioimaging and medical diagnostics to security and wireless communications. We propose a tunable terahertz coherent radiation source based on graphene plasmon-induced transition radiation. The transition radiation in terahertz regime arises from the graphene plasmons, which are excited by a normally incident bunched electron beam. We analyze the field-intensities and spectral-angular distributions of the transition radiation with respect to Fermi energy, substrate dielectric permittivity, and electron bunch energy for both the coherent and incoherent radiation. The effect of electron bunching on the radiation pattern is discussed. The mechanism of plasmon frequency-selective transition radiation is discovered.

5.
Neurol Med Chir (Tokyo) ; 50(5): 361-6, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20505289

RESUMO

Erythropoietin (EPO) has a neuroprotective effect in the animal model of ischemia/hypoxia, but the mechanisms underlying the EPO effect in traumatic brain injury (TBI) are not well understood. This study examined the potential neuroprotective mechanisms of recombinant human EPO (rhEPO) in rats after TBI. Sixty healthy adult male Sprague-Dawley rats were randomly divided into 5 groups: 1000 U/kg rhEPO-treated, 3000 U/kg rhEPO-treated, 5000 U/kg rhEPO-treated, citicoline, and normal saline (control) groups. The TBI model was based on the modified Feeney's free falling model. Serum samples were collected at 6 hours, 24 hours, 3 days, 5 days, and 7 days after trauma. The serum S100B protein and interleukin-6 (IL-6) levels were measured after treatment in each group with double antibody sandwich enzyme-linked immunosorbent assay. Both serum S100B protein and IL-6 levels were significantly lower in 3000 U/kg rhEPO-treated and 5000 U/kg rhEPO-treated groups (p < 0.001). The decrease in serum S100B protein level was correlated with the dosage of rhEPO. Medium doses of rhEPO achieved the optimum decreases in the serum IL-6 level. Therefore, inhibition of the composition and secretion of S100B protein and IL-6 levels by EPO might be one of the mechanisms involved in decreasing inflammatory reaction in the brain, and may be responsible for the neuroprotective effect after TBI.


Assuntos
Lesões Encefálicas/patologia , Eritropoetina/farmacologia , Inflamação/prevenção & controle , Interleucina-6/sangue , Fatores de Crescimento Neural/sangue , Fármacos Neuroprotetores/farmacologia , Proteínas S100/sangue , Animais , Lesões Encefálicas/sangue , Lesões Encefálicas/complicações , Citidina Difosfato Colina/farmacologia , Relação Dose-Resposta a Droga , Humanos , Inflamação/sangue , Inflamação/patologia , Masculino , Fatores de Crescimento Neural/efeitos dos fármacos , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes , Subunidade beta da Proteína Ligante de Cálcio S100 , Proteínas S100/efeitos dos fármacos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA